Lidoderm 5 % Topical Patch — Competitive Intelligence Brief

Lidoderm 5 % Topical Patch (Lidoderm 5 % Topical Patch) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic. Area: Pain management / Dermatology.

marketed Local anesthetic Voltage-gated sodium channels Pain management / Dermatology Small molecule

Target snapshot

Lidoderm 5 % Topical Patch (Lidoderm 5 % Topical Patch) — Oregon Health and Science University. Lidocaine blocks sodium channels in nerve fibers, interrupting pain signal transmission when applied topically to the skin.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Lidoderm 5 % Topical Patch TARGET	Lidoderm 5 % Topical Patch	Oregon Health and Science University	marketed	Local anesthetic	Voltage-gated sodium channels
Topical Benzocaine 20%	Topical Benzocaine 20%	Nourhan M.Aly	marketed	Local anesthetic	Voltage-gated sodium channels
Continuous Infusion of ropivacaine 0.2%	Continuous Infusion of ropivacaine 0.2%	University of California, San Diego	marketed	Local anesthetic	Voltage-gated sodium channels
Topical Lidocaine 4% Cream	Topical Lidocaine 4% Cream	Children's Hospital of Philadelphia	marketed	Local anesthetic	Voltage-gated sodium channels
Topical liquid lidocaine	Topical liquid lidocaine	OHSU Knight Cancer Institute	marketed	Local anesthetic	Voltage-gated sodium channels
Topical Benzocaine	Topical Benzocaine	University of Maryland, Baltimore	marketed	Local anesthetic	Voltage-gated sodium channels
Lamotrigine tablet	Lamotrigine tablet	Dhaka Medical College	marketed	Anticonvulsant / Mood stabilizer	Voltage-gated sodium channels; glutamate release inhibition

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic class)

1. University of California, San Diego · 3 drugs in this class
2. Durect · 3 drugs in this class
3. Pacira Pharmaceuticals, Inc · 3 drugs in this class
4. Wake Forest University Health Sciences · 3 drugs in this class
5. Medical University of Vienna · 3 drugs in this class
6. Imperial College London · 2 drugs in this class
7. Hvidovre University Hospital · 2 drugs in this class
8. Innocoll · 2 drugs in this class
9. George Washington University · 2 drugs in this class
10. Guy's and St Thomas' NHS Foundation Trust · 2 drugs in this class